11:24 EDT Dyne Therapeutics (DYN) trading resumes
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DYN:
- Dyne Therapeutics trading halted, volatility trading pause
- Dyne Therapeutics price target lowered to $13 from $34 at Oppenheimer
- Dyne Therapeutics: Promising Advancements and FDA Support Drive Buy Rating
- Dyne Therapeutics Gains FDA Breakthrough Designation for DYNE-251
- Dyne Therapeutics announces FDA BTD to DYNE-251